<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sampath C</submitter><funding>NIAID NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>477-487</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9583701</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Periodontal Disease (PD), a chronic inflammatory disease, is highly prevalent among Persons Living With HIV (PLWH) and is characterized by microbial symbiosis and oxidative stress. Our hypothesis stipulates that periodontal therapy attenuates systemic inflammatory and bacterial burden while improving periodontal status in PLWH.&lt;h4>Methods&lt;/h4>Sixteen African Americans (AA) with suppressed HIV viremia on long-term Antiretroviral Therapy (ART) were recruited to this study. Participants were placed into two groups, based on their dental care status: group 1 (In-Care, IC) and group 2 (Out of Care, OC). Periodontal health was investigated at baseline, 3 months, 6 months, and 12 months. Cytokine/chemokines, microbial phyla, and Asymmetric Dimethylarginine (ADMA, a marker for</pubmed_abstract><journal>Journal of dental applications</journal><pubmed_title>Periodontal Treatment Reduces Circulating Pro-Inflammatory Cytokine and Chemokine Levels in African American HIV+ Individuals with Virological Suppression.</pubmed_title><pmcid>PMC9583701</pmcid><funding_grant_id>P30 AI110527</funding_grant_id><funding_grant_id>SC1 GM121282</funding_grant_id><pubmed_authors>Southerland JH</pubmed_authors><pubmed_authors>Sampath C</pubmed_authors><pubmed_authors>Harris EP</pubmed_authors><pubmed_authors>Wilus DM</pubmed_authors><pubmed_authors>Koethe JR</pubmed_authors><pubmed_authors>Tabatabai MA</pubmed_authors><pubmed_authors>Webster-Cyriaque J</pubmed_authors><pubmed_authors>Moss K</pubmed_authors><pubmed_authors>Berthaud V</pubmed_authors><pubmed_authors>Crayton MA</pubmed_authors><pubmed_authors>Gangula PR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Periodontal Treatment Reduces Circulating Pro-Inflammatory Cytokine and Chemokine Levels in African American HIV+ Individuals with Virological Suppression.</name><description>&lt;h4>Introduction&lt;/h4>Periodontal Disease (PD), a chronic inflammatory disease, is highly prevalent among Persons Living With HIV (PLWH) and is characterized by microbial symbiosis and oxidative stress. Our hypothesis stipulates that periodontal therapy attenuates systemic inflammatory and bacterial burden while improving periodontal status in PLWH.&lt;h4>Methods&lt;/h4>Sixteen African Americans (AA) with suppressed HIV viremia on long-term Antiretroviral Therapy (ART) were recruited to this study. Participants were placed into two groups, based on their dental care status: group 1 (In-Care, IC) and group 2 (Out of Care, OC). Periodontal health was investigated at baseline, 3 months, 6 months, and 12 months. Cytokine/chemokines, microbial phyla, and Asymmetric Dimethylarginine (ADMA, a marker for</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T23:19:48.15Z</modification><creation>2025-04-04T23:19:48.15Z</creation></dates><accession>S-EPMC9583701</accession><cross_references><pubmed>36274905</pubmed></cross_references></HashMap>